Get started
Author

Qisheng Hao

ORCID: 0009-0004-3258-4781
Observed ORCID: 0009-0004-3258-4781
OpenAlex ID: A5113301821
Da Vinci robot-assisted retroperitoneal tumor resection in 105 patients: a single-center experience
2024 · Qisheng Hao, Lichao Cha, et al. · Frontiers in Oncology · 7
PDF
Efficacy and safety of the combination of anlotinib and envafolimab in the treatment of unresectable or metastatic liposarcoma: findings from a single-center retrospective study
2025 · Hongliang Liu, Qisheng Hao, et al. · Frontiers in Oncology · 4
PDF
Clinical efficacy and learning curve analysis of 101 robotic-assisted Warshaw procedures: a retrospective study
2025 · Hongliang Liu, Qisheng Hao, et al. · Surgical Endoscopy · 3
PDF
Kimura or Warshaw? Development and Validation of a Preoperative Prediction Model Based on 3D Reconstruction Technology
2025 · Hongliang Liu, Qisheng Hao, et al. · Annals of Surgical Oncology · 1
PDF
Prognostic impact of total (Ipsilateral) retroperitoneal lipectomy vs. complete resection in retroperitoneal liposarcoma: A retrospective cohort study with nomogram
2025 · Qisheng Hao, Qingze Li, et al. · European Journal of Surgical Oncology · 1
PDF
The Burden of Pancreatic Cancer in ASEAN Member States (1990–2023) and Future Trends Forecasting: A GBD 2023 Analysis
2026 · Kang Fu, Yangdong Wu, et al. · Mayo Clinic Proceedings
PDF
Works count: 6
Citation count: 16
H-index: 3
I10-index:
Year
Topic
Type